Enno Schmidt
#155,479
Most Influential Person Now
Researcher
Enno Schmidt's AcademicInfluence.com Rankings
Enno Schmidtcomputer-science Degrees
Computer Science
#8511
World Rank
#8947
Historical Rank
Machine Learning
#3502
World Rank
#3545
Historical Rank
Artificial Intelligence
#3806
World Rank
#3861
Historical Rank
Database
#5512
World Rank
#5719
Historical Rank
Download Badge
Computer Science
Enno Schmidt's Degrees
- PhD Computer Science ETH Zurich
- Masters Computer Science University of Zurich
- Bachelors Computer Science University of Zurich
Similar Degrees You Can Earn
Why Is Enno Schmidt Influential?
(Suggest an Edit or Addition)Enno Schmidt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pemphigoid diseases (2013) (679)
- Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. (2000) (321)
- Mechanisms of Autoantibody-Induced Pathology (2017) (295)
- Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. (2012) (274)
- Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany (2009) (256)
- Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. (2018) (197)
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) (2011) (189)
- Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. (2002) (186)
- Modern diagnosis of autoimmune blistering skin diseases. (2010) (175)
- IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. (2000) (174)
- Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial (2017) (154)
- Rituximab in autoimmune bullous diseases: mixed responses and adverse effects (2007) (153)
- Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases § (2008) (148)
- Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management (2018) (139)
- Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. (1999) (136)
- Rituximab in refractory autoimmune bullous diseases (2006) (135)
- Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. (2016) (135)
- Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies (2007) (134)
- Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. (2011) (134)
- Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra‐ and extracellular domains of bullous pemphigoid antigen 180 (2001) (129)
- Pemphigus (2019) (124)
- Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients (2010) (123)
- Pemphigoid diseases: Pathogenesis, diagnosis, and treatment (2012) (117)
- Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy (2012) (116)
- Clinical features and practical diagnosis of bullous pemphigoid. (2011) (116)
- Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. (1998) (115)
- Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. (2000) (114)
- Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) (2020) (112)
- S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid (2015) (108)
- Rituximab in Severe Pemphigus (2009) (108)
- Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. (2011) (103)
- Clinical and immunopathological spectrum of paraneoplastic pemphigus (2010) (101)
- Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity (2017) (98)
- S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid (2015) (97)
- Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus (2003) (97)
- Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. (2011) (96)
- Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus* (2009) (96)
- Immunoadsorption in dermatology (2010) (96)
- The diagnosis and treatment of autoimmune blistering skin diseases. (2011) (96)
- Anti-p200 pemphigoid. (2014) (95)
- Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus. (2018) (94)
- Immunogenicity of rituximab in patients with severe pemphigus. (2009) (93)
- Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. (2013) (92)
- Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. (2009) (87)
- Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options. (2016) (87)
- Malignancies in pemphigus and pemphigoid diseases. (2015) (86)
- Genetic identification and functional validation of FcγRIV as key molecule in autoantibody‐induced tissue injury (2012) (84)
- Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. (2012) (83)
- Current therapy of the pemphigus group. (2012) (82)
- Diagnosis of autoimmune bullous diseases (2018) (81)
- Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. (2006) (81)
- Rituximab in Treatment-Resistant Autoimmune Blistering Skin Disorders (2008) (80)
- Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? (1999) (77)
- Development of a simple enzyme‐linked immunosorbent assay for the detection of autoantibodies in anti‐p200 pemphigoid (2011) (76)
- Diagnosis of Autoimmune Blistering Diseases (2018) (74)
- Long‐standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab (2005) (74)
- Epitope mapping of BP230 leading to a novel enzyme‐linked immunosorbent assay for autoantibodies in bullous pemphigoid (2012) (73)
- Structural proteins of the dermal‐epidermal junction targeted by autoantibodies in pemphigoid diseases (2017) (69)
- Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology (2016) (67)
- IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. (2019) (67)
- Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. (2011) (67)
- Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients (2012) (66)
- Bullous pemphigoid in infants: characteristics, diagnosis and treatment (2014) (65)
- Repetitive Immunization Breaks Tolerance to Type XVII Collagen and Leads to Bullous Pemphigoid in Mice (2011) (65)
- Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory. (2000) (64)
- Clinical features and diagnosis of epidermolysis bullosa acquisita (2017) (64)
- Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. (2014) (64)
- Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. (2011) (64)
- An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone (2017) (62)
- The IL‐8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone (2001) (61)
- IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. (1999) (60)
- IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases (2016) (60)
- Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid (1996) (59)
- Regulatory T‐cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease (2018) (58)
- International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita (2018) (55)
- Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic (2020) (55)
- Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases (2007) (54)
- Improvement of treatment-refractory atopic dermatitis by immunoadsorption: a pilot study. (2011) (53)
- Current treatment of autoimmune blistering diseases. (2009) (52)
- Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption (2006) (51)
- Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. (2013) (51)
- Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases (2012) (50)
- Serum levels of anti‐type VII collagen antibodies detected by enzyme‐linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions (2013) (50)
- The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita. (2017) (49)
- SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany (2020) (49)
- A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid (2018) (48)
- Neurological and psychiatric associations in bullous pemphigoid—more than skin deep? (2017) (48)
- Emerging treatments for pemphigoid diseases. (2013) (47)
- Genome‐wide association study identifies new susceptibility loci for cutaneous lupus erythematosus (2015) (47)
- Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus (2017) (47)
- Enzymatic autoantibody glycan hydrolysis alleviates autoimmunity against type VII collagen. (2012) (47)
- Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. (2019) (47)
- Prevalence of pemphigus and pemphigoid autoantibodies in the general population (2015) (47)
- Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. (1996) (47)
- BP180-specific IgG is associated with skin adverse events, therapy response and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. (2020) (46)
- Pathogenicity of Autoantibodies in Anti-p200 Pemphigoid (2012) (46)
- Apoptosis is not required for acantholysis in pemphigus vulgaris. (2009) (45)
- Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases (2017) (45)
- Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis (2016) (45)
- Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen (2002) (44)
- Sun‐Induced Life‐Threatening Lupus Nephritis (2007) (43)
- Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid. (2016) (43)
- European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II (2021) (43)
- Caspase-1–Independent IL-1 Release Mediates Blister Formation in Autoantibody-Induced Tissue Injury through Modulation of Endothelial Adhesion Molecules (2015) (42)
- Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease. (2017) (41)
- Prospective studies on the routine use of a novel multivariant enzyme‐linked immunosorbent assay for the diagnosis of autoimmune bullous diseases (2017) (41)
- Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation. (2013) (41)
- Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid (2013) (40)
- Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2 (2018) (39)
- Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases (2017) (38)
- Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. (2002) (38)
- Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients (2006) (38)
- Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. (2011) (38)
- Animal models for autoimmune bullous dermatoses (2010) (37)
- Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID) (2015) (37)
- Protective Endogenous Cyclic Adenosine 5′-Monophosphate Signaling Triggered by Pemphigus Autoantibodies (2010) (36)
- GM-CSF Modulates Autoantibody Production and Skin Blistering in Experimental Epidermolysis Bullosa Acquisita (2014) (36)
- Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? (2009) (36)
- Apoptosis in pemphigus. (2009) (36)
- Rituximab as first-line treatment of pemphigus (2017) (35)
- Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus (2017) (35)
- Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus* (2009) (34)
- Immunoadsorption in Dermatology (2012) (34)
- Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice (2001) (33)
- S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update (2020) (33)
- Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease. (2019) (33)
- The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies. (2017) (33)
- Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. (2017) (33)
- Clinical and immunological features and outcome of anti‐p200 pemphigoid (2016) (32)
- Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab. (2009) (32)
- Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. (2012) (32)
- Histopathology of anti-laminin 5 mucous membrane pemphigoid. (2009) (31)
- Covid‐19 pandemic and the skin (2020) (31)
- Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. (2005) (30)
- Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. (2009) (29)
- Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment (2016) (29)
- Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. (2002) (29)
- Detection of IL-1α, IL-1β and IL-1 receptor antagonist in blister fluid of bullous pemphigoid☆ (1996) (29)
- A successful treatment with ustekinumab in a case of antilaminin‐γ1 pemphigoid associated with psoriasis (2013) (29)
- Co‐occurrence of autoantibodies in healthy blood donors (2014) (28)
- Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial * (2021) (28)
- Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting. (2009) (28)
- Clearance rates of circulating and tissue‐bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita (2010) (28)
- COVID‐19 and implications for dermatological and allergological diseases (2020) (27)
- Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins (2014) (27)
- Resolution in bullous pemphigoid (2019) (27)
- IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis. (2014) (27)
- Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins. (2003) (27)
- Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis (2018) (26)
- Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic (2021) (26)
- Epidemiology of Pemphigus (2021) (26)
- Prospective study in bullous pemphigoid: association of high serum anti‐BP180 IgG levels with increased mortality and reduced Karnofsky score (2018) (26)
- A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody‐induced mucosal blistering in pemphigus (2020) (25)
- Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid (2017) (25)
- European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I (2021) (25)
- Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature (2017) (25)
- CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion. (2001) (24)
- Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters. (2015) (24)
- The retinoid‐related orphan receptor alpha is essential for the end‐stage effector phase of experimental epidermolysis bullosa acquisita (2015) (24)
- EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non‐linear, V‐shaped relationship (2014) (24)
- Glucocorticosteroid‐resistant pemphigoid gestationis: Successful treatment with adjuvant immunoadsorption (2012) (23)
- Diagnosis and treatment of patients with autoimmune bullous disorders in Germany. (2011) (23)
- Diagnostic performance of the “MESACUP anti-Skin profile TEST” (2016) (23)
- Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita (2018) (23)
- Generalized cowpox infection in a patient with Darier disease (2011) (23)
- [Pemphigus. Loss of desmosomal cell-cell contact]. (2000) (23)
- Premonitory Epidermolysis Bullosa Acquisita Mimicking Eyelid Dermatitis (2010) (22)
- A distinct cutaneous microbiota profile in autoimmune bullous disease patients (2017) (22)
- Linear IgA Disease: Successful Application of Immunoadsorption and Review of the Literature (2010) (22)
- Serum autoantibodies against the dermal–epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited (2014) (22)
- CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab (2008) (22)
- Diagnostics of autoimmune bullous diseases in German dermatology departments (2012) (22)
- Elevated expression and release of tissue‐type, but not urokinase‐type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes (2004) (22)
- Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. (2019) (21)
- Prevalence and age distribution of pemphigus and pemphigoid diseases among paediatric patients in Germany (2020) (21)
- Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population (2015) (21)
- Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series. (2014) (21)
- Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases. (2015) (20)
- Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5. (2006) (20)
- Research in practice: diagnosis of subepidermal autoimmune bullous disorders (2009) (20)
- Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) (2022) (20)
- Clinical features and practical diagnosis of bullous pemphigoid. (2012) (19)
- Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice (2018) (19)
- Epidemiology of Autoimmune Bullous Diseases (2015) (19)
- Relapse‐associated autoantibodies to BP180 in a patient with anti‐p200 pemphigoid (2009) (19)
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases (2022) (18)
- Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIPTM technology. (2020) (18)
- High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid. (1995) (18)
- Ca2+ signalling is critical for autoantibody‐induced blistering of human epidermis in pemphigus * (2020) (18)
- Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal–epidermal junction (2016) (17)
- Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid. (2018) (17)
- S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV) (2021) (17)
- Incidence of pemphigoid diseases in Northern Germany in 2016 – first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases (2021) (17)
- Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid. (2021) (17)
- Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption (2018) (16)
- Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita. (2017) (16)
- [Immunopathologic changes in 115 patients with bullous pemphigoid]. (1999) (16)
- A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. (2002) (16)
- Linear IgA disease with circulating IgA antibodies against the NC16A domain of BP180 (1999) (16)
- Identification of novel therapeutic targets for blocking acantholysis in pemphigus (2020) (15)
- A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial. (2017) (15)
- Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid (2015) (15)
- A long‐term study of a patient with anti‐p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading (2012) (15)
- Long‐term outcomes of rituximab therapy in pemphigus (2020) (14)
- Bullous Autoimmune Dermatoses: Clinical Features, Diagnostic Evaluation, and Treatment Options. (2021) (14)
- Milestones in Personalized Medicine in Pemphigus and Pemphigoid (2021) (14)
- The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris—Analysis of Four Different Ethnic Cohorts (2018) (13)
- Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice (2020) (13)
- Assessment of healthcare costs for patients with pemphigus and bullous pemphigoid in an academic centre in Germany (2019) (13)
- Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial (2018) (13)
- Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid (2017) (13)
- Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients. (2015) (13)
- Antibodies to the C-terminus of laminin γ1 are present in a distinct subgroup of patients with systemic and cutaneous lupus erythematosus (2012) (13)
- Therapeutic effect of etanercept in anti‐laminin 5 (laminin 332) mucous membrane pemphigoid (2011) (12)
- Paraneoplastic pemphigus with anti‐BP180 autoantibodies and Castleman disease (2017) (12)
- Recent progresses and perspectives in autoimmune bullous diseases. (2020) (12)
- Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co‐morbidities (2021) (12)
- Bullous pemphigoid with localized umbilical involvement. (2009) (12)
- [Treatment-refractory anti-laminin 332 mucous membrane pemphigoid. Remission following adjuvant immunoadsorption and rituximab]. (2011) (11)
- Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin (2017) (11)
- Value of BIOCHIP Technology in the Serological Diagnosis of Pemphigoid Gestationis. (2017) (11)
- Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases. (2021) (11)
- The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study (2021) (11)
- Vitamin D status in patients with bullous pemphigoid (2013) (11)
- Serological characterization of anti-p200 pemphigoid: Epitope spreading as a common phenomenon. (2020) (10)
- Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180‐NC16A‐specific IgG antibodies in bullous pemphigoid (2019) (10)
- IgE-Selective Immunoadsorption for Severe Atopic Dermatitis (2018) (10)
- Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid. (1996) (10)
- Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides. (2012) (10)
- Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti‐BP230 seropositivity (2021) (9)
- A Family with Atypical Hailey Hailey Disease- Is There More to the Underlying Genetics than ATP2C1? (2015) (9)
- Increased sensitivity and high specificity of indirect immunofluorescence in detecting IgG subclasses for diagnosis of bullous pemphigoid (2018) (9)
- Automated direct immunofluorescence analyses of skin biopsies (2016) (9)
- The burden of neurological comorbidities in six autoimmune bullous diseases: a population‐based study (2021) (9)
- EndoS Reduces the Pathogenicity of Anti-mCOL7 IgG through Reduced Binding of Immune Complexes to Neutrophils (2014) (8)
- Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid (2021) (8)
- Diagnosis and clinical severity markers of bullous pemphigoid (2009) (8)
- More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study (2020) (8)
- Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting (2016) (8)
- Eczematous reaction to intravenous immunoglobulin: an alternative cause of eczema. (2014) (8)
- Late‐onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII (2011) (8)
- The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid (2021) (8)
- International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid (2021) (8)
- Bullous pemphigoid autoantibody‐mediated complement fixation is abolished by the low‐molecular‐weight heparin tinzaparin sodium (2019) (8)
- Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of “Fogo Selvagem” Pemphigus Foliaceus (2019) (8)
- Anti‐laminin 332 mucous membrane pemphigoid with laryngeal involvement – adjuvant treatment with immunoadsorption and rituximab (2018) (7)
- Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid (2020) (7)
- Penile mucous membrane pemphigoid (2020) (6)
- Chronic bullous disease of childhood with IgG reactivity to p200 antigen (2017) (6)
- [Dermatology at the University Hospital of Mbarara, Uganda]. (2004) (6)
- [New aspects on the pathogenesis of bullous pemphigoid]. (2000) (6)
- Grover disease and bullous pemphigoid: a clinicopathological study of six cases (2018) (6)
- Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans (2021) (6)
- Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid—Insights from a Retrospective Cohort Study (2020) (5)
- Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti‐BP180 autoantibodies (2020) (5)
- Genetic variability of immune‐related lncRNAs: polymorphisms in LINC‐PINT and LY86‐AS1 are associated with pemphigus foliaceus susceptibility (2021) (5)
- Travel‐associated infectious skin diseases (2020) (5)
- Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus. (2021) (5)
- [Optimizing therapy in patients with severe autoimmune blistering skin diseases]. (2009) (5)
- Expression of PD‐1 and Tim‐3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris (2020) (5)
- HLA alleles in British Caucasians with mucous membrane pemphigoid (2018) (5)
- The relevance of complement in pemphigoid diseases: A critical appraisal (2022) (5)
- A refractory, cutaneous, subepidermal bullous disease (2016) (5)
- On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in Germany. (2022) (5)
- The Association of Bullous Pemphigoid With Atopic Dermatitis and Allergic Rhinitis—A Population-Based Study (2021) (5)
- Prevalence and presumptive triggers of localized bullous pemphigoid (2021) (4)
- Evaluation and Comparison of Clinical and Laboratory Characterstics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita. (2021) (4)
- Tibial bone keratoprosthesis: reversing blindness in mucous membrane pemphigoid (2017) (4)
- Bullous pemphigoid with linear lesions and antibodies exclusively against the soluble ectodomain of BP180 (LAD‐1) (2019) (4)
- Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption. (2012) (4)
- Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid (2020) (4)
- Concomitant Bullous Pemphigoid and Dermatitis Herpetiformis (2013) (4)
- Diagnostic Value and Practicability of Serration Pattern Analysis by Direct Immunofluorescence Microscopy in Pemphigoid Diseases (2021) (4)
- 424 Cell-based immunofluorescence test applying recombinant laminin 332 for the serological differential diagnosis of pemphigoid (2017) (4)
- Contemporary management of pemphigus (2013) (4)
- The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study (2021) (4)
- Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease (2021) (4)
- From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases. (2014) (4)
- C5aR2 deficiency ameliorates inflammation in murine epidermolysis bullosa acquisita by regulating FcγRIIb expression on neutrophils. (2022) (3)
- Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid. (2016) (3)
- Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid With Concomitant Anti-Contactin-1-Positive Inflammatory Polyneuropathy Treated With Intravenous Immunoglobulins as a Manifestation of Epitope Spreading. (2019) (3)
- Immunadsorption in der Dermatologie (2018) (3)
- Increasing the diagnostic sensitivity for mucous membrane pemphigoid by detection of salivary autoantibodies (2016) (3)
- Clinical and Serological Characterization of Orf-Induced Immunobullous Disease. (2022) (3)
- Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans (2019) (3)
- A novel epitope within the BP180 NC16A domain is targeted by autoantibodies in lichen planus pemphigoides (1998) (3)
- Diagnostic Value of Linear Fluorescence Along the Basement Membrane of Sweat Gland Ducts in Bullous Pemphigoid. (2017) (3)
- 068 Serological characterization of anti-p200 pemphigoid: Epitope spreading as a common phenomenon (2019) (3)
- [Multiple papules and nodules and on the scrotum of a 34 year-old patient]. (2003) (3)
- Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases (2021) (3)
- A childhood subepidermal autoimmune bullous disease resembling mechanobullous epidermolysis bullosa acquisita (2015) (3)
- Immunological features and factors associated with mucocutaneous bullous pemphigoid – a retrospective cohort study (2021) (3)
- Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes: functionally relevant modification by calcium (2006) (3)
- Pathogenic Activation and Therapeutic Blockage of Fc Alpha Receptor-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus. (2021) (2)
- Human type VII collagen harbors multiple pathogenically relevant epitopes (2013) (2)
- Longstanding painful hemorrhagic vesicles and erosions on the lower leg. (2011) (2)
- Natural occurrence of autoantibodies against basement membrane proteins in epidermolysis bullosa. (2021) (2)
- Doxycycline vs. prednisolone for initial treatment of bullous pemphigoid: a pragmatic noninferiority randomized controlled trial (2016) (2)
- Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses (2023) (2)
- Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice (2021) (2)
- Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus (2023) (2)
- Trehalose conserves expression of bullous pemphigoid antigen 180 during desiccation and freezing. (2003) (2)
- Autoantibodies in epidermolysis bullosa (2018) (2)
- Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid (2021) (2)
- Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity (2021) (2)
- Multiple modes of action mediate the therapeutic effect of IVIg in experimental epidermolysis bullosa acquisita. (2021) (2)
- Low prevalence of late-onset neutropenia following rituximab treatment in patients with pemphigus. (2020) (2)
- Unsuspected Associations with Variants within the Genes NOTCH4 and STEAP2-ASI Uncovered by a Genome-Wide Association Study in Endemic Pemphigus Foliaceus. (2021) (2)
- Heavy Exposure of Children Aged 9–12 Years With Severe Acute Respiratory Syndrome Coronavirus 2 Did Not Lead to Infection (2020) (2)
- Anti‐desmoglein 1 IgG/IgA pemphigus associated with thymoma (2017) (2)
- Meeting report - Desmosome dysfunction and disease: Alpine desmosome disease meeting. (2023) (2)
- 47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) (2021) (2)
- The association of six autoimmune bullous diseases with thyroid disorders: a population‐based study (2022) (2)
- Mast cell‐deficient mice Mcpt5Cre/Dicer fl/fl redefine the role of mast cells in experimental bullous pemphigoid (2021) (2)
- S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) (2)
- [Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]. (2018) (2)
- Recombinant IL-6 treatment protects mice from organ-specific autoimmune disease by induction of IL-1ra, mediated by classical IL-6 signaling (2012) (1)
- [Autoimmune bullous dermatoses : Update on treatments and rare forms]. (2019) (1)
- Faculty Opinions recommendation of Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial. (2020) (1)
- Faculty Opinions recommendation of Keratinocyte footprint assay discriminates anti-laminin-332 pemphigoid from all other forms of pemphigoid diseases. (2019) (1)
- Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases (2022) (1)
- Genome-wide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid (2018) (1)
- Apremilast prevents blistering in human epidermis by stabilization of keratinocyte adhesion in pemphigus (2022) (1)
- Genetic and Environmental Risk Factors of Autoimmune Bullous Diseases (2015) (1)
- Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders (2022) (1)
- [Autoimmune blistering skin diseases: diagnostic and therapeutic approach]. (2014) (1)
- Detection of u-serrated patterns in direct immunofluorescence images of autoimmune bullous diseases by inhibition-augmented COSFIRE filters (2019) (1)
- Immunoglobulin M mucous membrane pemphigoid (2023) (1)
- Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase (2022) (1)
- 089 Sensitive and specific assay for the serological diagnosis of anti-laminin 332 mucous membrane pemphigoid (2018) (1)
- Anti-BP230 only bullous pemphigoid constitutes a distinct disease subgroup with characteristic serological and clinical features. (2022) (1)
- The BLISTER study: possible overestimation of tetracycline efficacy – Authors' reply (2017) (1)
- Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients (2022) (1)
- Case Report of a Novel Association between Anti-p200 Pemphigoid and Acquired Haemophilia A (2023) (1)
- Pemphigus Foliaceus and Pemphigus Erythematosus (2015) (1)
- Immunoglobulin M pemphigoid (2021) (1)
- Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection. (2020) (1)
- 335 Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIPTM technology (2017) (1)
- Post‐orf epidermolysis bullosa acquisita (2018) (1)
- Coincidence of Bullous Pemphigoid and Pityriasis Rubra Pilaris (2022) (1)
- Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study (2022) (1)
- Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris (2022) (1)
- Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus (2022) (1)
- [Modern diagnostics of autoimmune bullous diseases]. (2020) (1)
- Different pathogenicity of IgG subclasses in experimental epidermolysis bullosa acquisita (2013) (0)
- ILDS Newsletter No. 12/2010 (2010) (0)
- Corrigendum to “Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction” [J Autoimmun 40C (2013) 74–85] (2015) (0)
- 048 Possible complement-independent mechanisms in tissue destruction in bullous pemphigoid (2018) (0)
- Pathogenicity of anti-desmoglein 3 IgA1 autoantibodies is Fc-dependent in IgA pemphigus (2019) (0)
- Case of subepidermal blistering disease with autoantibodies to both laminin‐γ1 and laminin‐α3 (2013) (0)
- Psoriasis and skin diseases (PP-055) (2010) (0)
- Paraneoplastic pemphigus with anti-BP 180 autoantibodies and Castleman ' s disease Short title : Paraneoplastic pemphigus with anti-BP 180 IgG autoantibodies (2016) (0)
- HRT–Measurements Of Topographic Changes Induced By Macular Hole Surgery (2004) (0)
- [Primary antiphospholipid syndrome: newly developed leg ulcer and history of stroke]. (2013) (0)
- Intraindividual Variability of Optic Disc Parameters (2009) (0)
- [85-year-old male with cutaneous blisters : Preparation for the medical specialist examination: Part 25]. (2018) (0)
- Allelic and copy number variations in human Fc gamma receptor genes are strongly associated with susceptibility to autoimmune blistering diseases (AIBD) (2013) (0)
- Author Correction: Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus (2023) (0)
- Detlef Zillikens, 1958-2022 (2023) (0)
- Faculty Opinions recommendation of Establishment of a mouse model of atopic dermatitis by deleting ikk2 in dermal fibroblasts. (2019) (0)
- Lymphoma, Hematological Neoplasia, and Metastases of the Oral Cavity (2021) (0)
- [Therapy of pemphigus]. (2019) (0)
- 064 Impaired peripheral tolerance leads to AIBD phenotype with pathogenic antibodies and blister formation (2018) (0)
- Medical History and Clinical Examination (2021) (0)
- Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions (2023) (0)
- 324 IL-17A is a key regulator in experimental bullous pemphigoid (2017) (0)
- Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance (2022) (0)
- Pemphigoid in Mice Type XVII Collagen and Leads to Bullous Repetitive Immunization Breaks Tolerance to (2011) (0)
- Epidermolysis bullosa acquisita: the most frequent pemphigoid disease in patients with dermal binding autoantibodies by indirect immunofluorescence microscopy on human salt‐split skin in Tehran, Iran (2021) (0)
- 490 Adjuvant immunoadsorption in severe and/or refractory bullous pemphigoid (2017) (0)
- Track Z (FS). FS: Novel developments in the diagnosis and treatment of autoimmune blistering diseases. (2015) (0)
- Inhibition of phosphatidylinositol-3-kinase δ improves tissue destruction in pemphigoid diseases by impairing neutrophil function (2019) (0)
- A rare bullous variant of dermatitis herpetiformis (2016) (0)
- Arylhydrocarbon receptor activation promotes epidermal barrier formation and attenuates Th2-cytokine dependent inflammatory processes: The biological basis of coal tar therapy in atopic dermatitis (2010) (0)
- Faculty Opinions recommendation of Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin. (2020) (0)
- Front & Back Matter (2012) (0)
- Faculty Opinions recommendation of Myeloperoxidase modulates inflammation in generalized pustular psoriasis and additional rare pustular skin diseases. (2020) (0)
- Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease. (2022) (0)
- Faculty Opinions recommendation of Targeting inducible costimulator expressed on CXCR5+PD-1+ TH cells suppresses the progression of pemphigus vulgaris. (2020) (0)
- LB773 Treating pemphigus vulgaris (PV) and foliaceus (PF) by inhibiting the neonatal Fc receptor: Phase 2 multicentre open-label trial with efgartigimod (2021) (0)
- 011 Targeted inhibition of complement C3 deposition at the basement membrane zone in pemphigoid disease (2022) (0)
- 067 Laminin beta4: A protein of the cutaneous basal membrane zone and autoantigen of anti-p200 pemphigoid (2023) (0)
- Corrigendum (2019) (0)
- 075 Inhibition of phosphodiesterase-4 significantly decreases oral mucosa lesions in experimental anti-laminin 332 mucous membrane pemphigoid (2019) (0)
- Distinct metabolite profile in pemphigus vulgaris. (2022) (0)
- Meetings, transactions and society news (2003) (0)
- Faculty Opinions recommendation of Autoantibodies to bpag1e trigger experimental bullous pemphigoid in mice. (2020) (0)
- Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic (2016) (0)
- Life-Threatening Pemphigus Vulgaris (2015) (0)
- Autoimmune Blistering Diseases: An Introduction (2021) (0)
- Peniles Schleimhautpemphigoid (2020) (0)
- BP: serum anti‐BP180 IgG levels, mortality and Karnofsky score (2018) (0)
- Detection of autoantibodies in bullous pemphigoid, epidermolysis bullosa acquisita, and pemphigus vulgaris by indirect immunofluorescence with a BIOCHIP Mosaic (2011) (0)
- Distinct contributions of cytokines to autoantibody-induced tissue injury (2013) (0)
- 070 Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod (2022) (0)
- Faculty of 1000 evaluation for Low-dose rituximab is effective in pemphigus. (2012) (0)
- 311 Treatment of bullous pemphigoid by inhibiting fcrn: Pre-registration report of a phase 2/3 trial with efgartigimod (2022) (0)
- Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy-Related Outcomes in Patients With Mucous Membrane Pemphigoid. (2023) (0)
- AB0734 Prevalence and co-occurrence of autoantibodies in blood donors (2013) (0)
- University of Groningen Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment (2017) (0)
- [Anti-laminin 332 mucous membrane pemphigoid with irreversible ocular and tracheobronchial involvement : Delayed diagnosis of a severe autoimmune bullous disease]. (2019) (0)
- Faculty Opinions recommendation of Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease. (2020) (0)
- Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin (2020) (0)
- Single Step Multivariant Analysis of Serum Autoantibodies in Autoimmune Blistering Diseases Using BIOCHIP® Mosaic Technology (2015) (0)
- Running Title: A Rare Bullous Variant of Dermatitis Herpetiformis (2015) (0)
- 59 Immunoadsorption in autoimmune bullous disorders (2010) (0)
- University of Groningen Whole-genome expression Profiling in skin reveals sYK as a Key regulator of inflammation in experimental epidermolysis Bullosa acquisita Samavedam, (2018) (0)
- Faculty Opinions recommendation of Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. (2016) (0)
- 036 Targeted inhibition of complement at the basement-membrane zone in pemphigoid diseases (2019) (0)
- [Young woman with new vesiculobullous eruptions]. (2023) (0)
- 062 Sera of patients with bullous pemphigoid and mucous membrane pemphigoid react with a C-terminal 246 amino acid stretch of BP180 (2019) (0)
- Systemic lupus erythematosus. Unusual cutaneous manifestations (2016) (0)
- Detection of pemphigus autoantibodies by new ELISA and indirect immunofluorescence test systems (2010) (0)
- Track Z. Special Focus Sessions (2015) (0)
- [Persistent papule/mole blisters/pustules papulary pustels on the face of a 21-year old man]. (2003) (0)
- Faculty Opinions recommendation of Prognostic factors of paraneoplastic pemphigus. (2012) (0)
- Serological diagnosis of autoimmune dermatoses: Dermatology Mosaic 9 (Order number: FA 1501-9) (2009) (0)
- 370 Anti-desmoglein 3 autoantibodies cloned from the IgA1 repertoire of an IgA pemphigus patient are directly pathogenic, but not sufficient for disease induction (2017) (0)
- A teenager with blisters and crusts (2022) (0)
- Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus (2017) (0)
- Faculty Opinions recommendation of TSST-1+Staphylococcus aureus in Bullous pemphigoid. (2021) (0)
- Conservation scores and frequencies of SNPs in ATPase genes found in a Greek Family with atypical Hailey Hailey disease. (2015) (0)
- Miscellaneous Disorders with Oral Manifestations (2021) (0)
- S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). (2023) (0)
- Patterns of biological therapy use in the management of psoriasis (2016) (0)
- Editorial: Autoimmune blistering diseases, volume II (2023) (0)
- How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey (2022) (0)
- Analysis of T cell repertoires of CD45RO CD4 T cells in cohorts of patients with bullous pemphigoid: A pilot study (2022) (0)
- 372 Inhibition of phosphatidylinositol-3-kinase δ improves tissue destruction in pemphigoid diseases by impairing neutrophil function (2019) (0)
- Effect of phosphodiesterase-4 inhibition on skin and mucosal lesions in experimental anti-laminin 332 mucous membrane pemphigoid (2019) (0)
- Pathogenic autoantibody derived from Treg-deficient scurfy mice targets Col7 and leads to Epidermolysis bullosa acquisita-like blistering disease. (2021) (0)
- Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris (2022) (0)
- Induction of acantholytic blisters by autoantibodies from pemphigus patients in the SCID-hu xenogeneic transplantation model (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Enno Schmidt?
Enno Schmidt is affiliated with the following schools:
